Skip to main content
. 2019 Aug 19;18:631–643. doi: 10.17179/excli2019-1447

Figure 2. Figure 2A-D: Meta-analysis of glycemic control weighted mean difference estimates for A) FPG, B) insulin, C) HOMA-IR, D) HbA1c in the L-carnitine supplements and placebo groups (CI=95 %).

Figure 2

Different capital letters indicate various dosage of L-carnitine used and different phases of L-carnitine treatment